ZCM
ARNA

Zebra Capital Management’s Arena Pharmaceuticals Inc ARNA Stock Holding History

Zebra Capital Management’s Portfolio ARNA Stock Details ARNA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q3 		– Sell
-4,361
Closed -$275K – 304
2020
Q2 		$275K Buy
+4,361
New +$240K 0.4% 102
2020
Q1 		– Sell
-4,900
Closed -$223K – 298
2019
Q4 		$223K Buy
+4,900
New +$232K 0.2% 217

Other funds holding ARNA

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return
Lord, Abbett & Co
Lord, Abbett & Co Jersey City, New Jersey $30.6B AUM 57.44% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Alkeon Capital Management
Alkeon Capital Management New York $59.5B AUM 51.63% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return
MWNA
Marshall Wace North America New York $23.5B AUM 46.46% 1-Year Est. Return

Zebra Capital Management's ARNA Position: Q3 2020 in Review

Zebra Capital Management sold out of Arena Pharmaceuticals Inc (ARNA) in Q3 2020, closing a stake of 4,361 shares — an estimated $275K sold.

Zebra Capital Management first reported a position in ARNA in Q4 2019 and held it in 2 quarters. The position peaked at $275K in Q2 2020. 253 funds tracked by Wall St. Rank hold ARNA as of Q3 2020.

  • Zebra Capital Management reported no remaining Arena Pharmaceuticals Inc position as of Q3 2020 after selling out during the quarter.
  • Zebra Capital Management sold 4,361 Arena Pharmaceuticals Inc shares in Q3 2020, an estimated $275K.
  • Zebra Capital Management first reported a position in Arena Pharmaceuticals Inc in Q4 2019 and held it in 2 quarters.
  • Zebra Capital Management's Arena Pharmaceuticals Inc position peaked at $275K in Q2 2020.
  • 253 funds tracked by Wall St. Rank held Arena Pharmaceuticals Inc as of Q3 2020.

Based on Zebra Capital Management's 13F filing for Q3 2020, filed 16 Nov 2020.